| AI | Artificial Intelligence |
| ALK | Anaplastic Lymphoma Kinase |
| ASR | Age-Standardized Rate |
| BCR-ABL | Breakpoint Cluster Region–Abelson Murine Leukaemia Viral Oncogene Homologue |
| BiTEs | Bispecific T-cell Engagers |
| BRAF | v-Raf Murine Sarcoma Viral Oncogene Homologue B |
| BRCA1/2 | Breast Cancer Gene 1/Breast Cancer Gene 2 |
| CAR-T | Chimeric Antigen Receptor T cells |
| CD | Cluster of Differentiation |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| CTLA-4 | Cytotoxic T-Lymphocyte–Associated Protein 4 |
| DNA | Deoxyribonucleic Acid |
| DPYD | Dihydropyrimidine Dehydrogenase |
| EGFR | Epidermal Growth Factor Receptor |
| EPA | Environmental Protection Agency |
| FDA | Food and Drug Administration |
| HBV | Hepatitis B Virus |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HPV | Human Papillomavirus |
| IARC | International Agency for Research on Cancer |
| ICIs | Immune Checkpoint Inhibitors |
| INFARMED | Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. |
| irAEs | Immune-related Adverse Events |
| ISOPP | International Society of Oncology Pharmacy Practitioners |
| KRAS | Kirsten Rat Sarcoma Viral Oncogene Homologue |
| LPHNPs | Lipid–Polymer Hybrid Nanoparticles |
| mAbs | Monoclonal Antibodies |
| MEK | Mitogen-Activated Protein Kinase |
| MSI | Microsatellite Instability |
| NIOSH | National Institute for Occupational Safety and Health |
| NRAS | Neuroblastoma RAS Viral Oncogene Homologue |
| NTRK | Neurotrophic Tyrosine Receptor Kinase |
| PARP | Poly (ADP-ribose) Polymerase |
| PD-1 | Programmed Cell Death Protein 1 |
| PD-L1 | Programmed Death-Ligand 1 |
| USP | United States Pharmacopoeia |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| WHO | World Health Organisation |
| 3D | Three-Dimensional |